Companies

Kiniksa Pharmaceuticals International, plc (KNSA) SEC filings

CIK 0001730430 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2021
Revenue (USD)677.6 M220.2 M
Net income (USD)-161.4 M-161.9 M
Diluted EPS (USD/shares)0.752.6

Latest filings

FiledFormDescriptionPeriod
2026-09-03442026-09-01
2026-09-03442026-09-01
2026-09-03442026-09-01
2026-09-03442026-09-01
2026-09-03442026-09-01
2026-09-03442026-07-15
2026-09-03144144
2026-08-21442026-08-19
2026-08-04442026-08-01
2026-07-31442026-07-29
2026-07-29144144
2026-07-29144144
2026-07-29SCHEDULE 13GSCHEDULE 13G
2026-07-2810-Q10-Q2026-06-30
2026-07-288-K8-K items 2.02,9.012026-07-28
2026-07-06442026-07-01
2026-07-06332026-06-29
2026-06-02442026-05-29
2026-06-02442026-05-29
2026-06-02442026-06-01
2026-06-02442026-05-29
2026-06-02442026-05-29
2026-06-02442026-05-29
2026-06-02442026-05-29
2026-06-02442026-05-29

Forms on file (last 1,000): 4 353, 144 88, 8-K 82, SC 13G/A 29, 10-Q 25, 3 24, SC 13G 18, CORRESP 15. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=KNSA (0.002 USD), /gw/filings/filings?ticker=KNSA&form=8-K, /gw/filings/facts?ticker=KNSA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange